EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough ...Middle East

Medscape - News
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result. Medscape Medical News

Hence then, the article about emperor preserved empagliflozin scores hfpef breakthrough was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough )

Apple Storegoogle play

Last updated :

Also on site :